Get this report today!
Table of Contents
The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing market studies, we found that outsourcing moved from "should" to "must." for manufacturers. This trend has only continued in the past two years.
Contract Research Organizations (CROs) and other entities can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to market is ever-increasing and intensifying. A key cost driver is the large number of failures during the expensive clinical trial phases. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry.
Kalorama Information's Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues.
As part of its comprehensive coverage of this market, this report contains:
Talk to Louis
+1 718 618 4302
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
This report analyzes the worldwide markets for ADME-Toxicology Testing in US$ Million by the following Product Segments: Toxicology Testing (In-Vivo, & In-Vitro), and ADME Testing. The report provides ...
This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 881 companies plus partners developing 1527 biological ...
PharmaLeaders: CRO Benchmark Report - Financial Performance Benchmarking & Competitive Landscape Assessment of Leading CROs Summary The CRO Benchmark Report applies GlobalData's proprietary ranking methodology ...
... Of patient or physician cohorts identified on disease, product , procedure or specialty. Optum clinformaticstm for clinical trials increase the efficiency and effectiveness of your clinical trial ...
... clinical trial management solutions biopharm systems mike grossman vice president, clinical data warehousing and analytics biopharm systems previous next i t oracle health sciences user group ...
Reportlinker.com © Copyright 2013. All rights reserved.